Literature DB >> 33393188

Coaction of hepatic thioredoxin and glutathione systems in iron overload-induced oxidative stress.

Feyza Sönmez Aydın1, Berna Hukkamlı1,2, Harun Budak1.   

Abstract

In the present study, we demonstrate the coaction of thioredoxin and glutathione (GSH) systems in mouse liver against iron overload-induced oxidative stress (OS). Mice were injected intraperitoneally with an iron dextran solution twice a week for 3 weeks. Iron accumulation in mouse liver was demonstrated spectroscopically. To confirm the iron overload model in the liver, the increased gene expression levels of hepcidin (Hamp), ferroportin (Fpn1), and ferritin (Fth1), which regulate iron trafficking, were observed by a quantitative polymerase chain reaction. In the case of iron overload, the GSH level and the reduced glutathione/oxidized glutathione ratio, which represents a marker of OS, decreased significantly. An increase in the malondialdehyde level, one of the final products of the lipid peroxidation process, was observed. The gene expression of the thioredoxin system, including thioredoxin (Trx1) and thioredoxin reductase (TrxR1), was examined. Though TrxR1 expression decreased, no changes were observed in Trx1. The enzyme activity and semiquantitative protein expression of TRXR1 increased. The activity of GSH reductase and GSH peroxidase increased in the iron overload group. The gene and protein expressions of thioredoxininteracting protein, which is an indicator of the commitment of the cell to apoptosis, were elevated significantly. The increased protein expression of Bcl-2-related X protein and CASPASE-3, which is an indicator of apoptosis, increased significantly. In conclusion, excess iron accumulation in mouse liver tissue causes OS, which affects the redox state of the thioredoxin and GSH systems, inducing cell apoptosis and also ferroptosis due to increased lipid peroxidation and the depletion of GSH level.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  glutathione system; iron overload; mouse liver; oxidative stress; thioredoxin system

Mesh:

Substances:

Year:  2021        PMID: 33393188     DOI: 10.1002/jbt.22704

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  6 in total

1.  Effects of Volatile Anaesthetics and Iron Dextran on Chronic Inflammation and Antioxidant Defense System in Rats.

Authors:  Dyana Odeh; Nada Oršolić; Emanuela Adrović; Lydia Gaćina; Petra Perić; Sahar Odeh; Vedran Balta; Nikola Lesar; Marina Kukolj
Journal:  Antioxidants (Basel)       Date:  2022-04-03

2.  Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11.

Authors:  Hui Dong; Yangyang Xia; Shanliang Jin; Chaofan Xue; Yanjun Wang; Rong Hu; Hong Jiang
Journal:  Cell Death Dis       Date:  2021-10-29       Impact factor: 8.469

3.  High Iron Exposure from the Fetal Stage to Adulthood in Mice Alters Lipid Metabolism.

Authors:  Minju Kim; Yeon-Hee Kim; Sohyun Min; Seung-Min Lee
Journal:  Nutrients       Date:  2022-06-13       Impact factor: 6.706

4.  Role of ferroptosis-related genes in coronary atherosclerosis and identification of key genes: integration of bioinformatics analysis and experimental validation.

Authors:  Qingwen Meng; Yiqian Xu; Xuebin Ling; Huajiang Liu; Shun Ding; Haolin Wu; Dongming Yan; Xingyue Fang; Tianfa Li; Qibing Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-29       Impact factor: 2.174

5.  Food-derived bioactive oligopeptide iron complexes ameliorate iron deficiency anemia and offspring development in pregnant rats.

Authors:  Wenfei Pan; He Gao; Xiaoling Ying; Caiju Xu; Xiang Ye; Yelin Shao; Mengdi Hua; Jie Shao; Xinxue Zhang; Shaowei Fu; Min Yang
Journal:  Front Nutr       Date:  2022-09-07

6.  An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.

Authors:  Yanfei Shao; Hongtao Jia; Ling Huang; Shuchun Li; Chenxing Wang; Batuer Aikemu; Guang Yang; Hiju Hong; Xiao Yang; Sen Zhang; Jing Sun; Minhua Zheng
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.